Results 211 to 220 of about 207,794 (393)

Idiopathic pulmonary fibrosis with complication of severe respiratory failure, right heart failure, and steroid induced diabetes – qualification for lung transplantation as a matter of urgency [PDF]

, 2016
Beata P. Kraśnicka-Sokół, Stanisław Laskowski, Krzysztof Kanafa, Marta Malinowska, Monika Bogulas, M Kochmański   +5 more
openalex   +1 more source

Pulmonary Vascular Endothelial Cells in Lung Diseases: Mechanisms, Therapeutic Strategies, and Future Directions

Cell Proliferation, EarlyView.
The pathogenic mechanisms of pulmonary vascular endothelial cells (VECs) in lung diseases and their multimodal therapeutic strategies. ABSTRACT Pulmonary vascular endothelial cells (VECs) are essential for the normal function of the lung, through maintaining vascular barrier integrity, regulating blood flow, and participating in inflammatory responses ...
Qianyue Liu, Hongshuai Zheng, Jing Liu, Ming Gao, Faquan Lin, Lin Liao   +5 more
wiley   +1 more source

Cognitive function in idiopathic pulmonary fibrosis [PDF]

, 2015
M Borş, Rade Tomic, D. Perlman, Hyun J. Kim, Timothy P. Whelan   +4 more
openalex   +1 more source

Tumor Development in Ulcerative Colitis: Perspectives From Biomechanical Characteristics

Development, Growth &Differentiation, EarlyView.
ABSTRACT Throughout our lifespan, sustaining orderly morphological structures for ensuring proper functioning of organs is imperative. Among these structures, the extracellular matrix (ECM) plays a pivotal role in sustaining organ and tissue homeostasis. Nevertheless, elucidating the role of abnormal ECM‐induced biomechanical microenvironmental changes
Hirotaka Tao
wiley   +1 more source

A matter arising: When should inflammatory and autoimmune rheumatic diseases be considered ‘early’?

European Journal of Clinical Investigation, EarlyView.
Timely recognition of inflammatory and autoimmune rheumatic diseases (IARDs) is important to optimize the early diagnosis with tailored interventions and possible prevention of irreversible organ damage. This narrative review provides an update by summarizing the advances in identifying the early stages of rheumatoid arthritis, systemic sclerosis and ...
Elvis Hysa, Emanuele Gotelli, Carmen Pizzorni, Sabrina Paolino, Alberto Sulli, Vanessa Smith, Rosanna Campitiello, Maurizio Cutolo   +7 more
wiley   +1 more source

The Role of Particle Inhalation in Idiopathic Pulmonary Fibrosis. [PDF]

Int J Mol Sci
Ghio AJ, Sangani RG, Todd NW.
europepmc   +1 more source

Fibroblast‐driven MMP‐9/TIMP‐1 imbalance in bronchoalveolar lavage reflects fibrotic progression in interstitial lung disease

European Journal of Clinical Investigation, EarlyView.
Abstract Background Interstitial lung diseases (ILDs) are characterized by progressive fibrosis, in which extracellular matrix remodelling is regulated by matrix metalloproteinases (MMPs) and their inhibitors (TIMPs). The MMP‐9/TIMP‐1 balance has been implicated in fibrogenesis, but its role in human ILD remains incompletely defined.
Maria Bertolotto, Daniela de Totero, Paolo Giannoni, Emanuela Barisione, Marco Grosso, Ennio Nano, Roberto Fiocca, Simona Pigozzi, Elisabetta Tedone, Luca Valle, Margherita Moriero, Daniela Verzola, Fabrizio Montecucco, Federico Carbone   +13 more
wiley   +1 more source

Identification of key genes associated with idiopathic pulmonary fibrosis and sarcopenia by bioinformatics analysis. [PDF]

PLoS One
Shen L, Yi Z, Liu J, Ying Y, Hu Y.
europepmc   +1 more source

Supplementary Material for: Insights from the German Compassionate Use Program of Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis

, 2016
Francesco Bonella, Michael Kreuter, Lars Hagmeyer, C Neurohr, Claus Keller, Martin Kohlhäeufl, Joachim Müller‐Quernheim, Katrin Milger, Antje Prasse   +8 more
openalex   +1 more source

Lung organoids as a human system for Mycobacteria infection modeling and drug testing

The FEBS Journal, EarlyView.
Mycobacterial infections, including tuberculosis (TB) and infections by nontuberculous mycobacteria (NTM), are still public health issues. In 2023, TB caused 1.25 million deaths, while NTM remain a clinical challenge for patients with cystic fibrosis (CF).
Stephen Adonai Leon‐Icaza, Romain Vergé, Raoul Mazars, Laurence Berry, Céline Cougoule   +4 more
wiley   +1 more source